Office Evaluation of Leg Pain

ABSTRACT

A successful office evaluation of a patient who presents with leg pain encompasses several factors and treatment decisions. Of course, the first goal of the evaluation is to determine the etiology of the leg pain. Following this, a complete history and physical examination is mandatory. Frequently at this point, additional imaging studies will become necessary. It is only at this point can various treatment options be explored. Clearly, the office evaluation of a patient with leg pain needs to be comprehensive. In addition, the initial evaluation establishes a relationship with the patient, one that will need to continue for some time even if a successful intervention is performed.

KEYWORDS

Leg pain - atherosclerosis - peripheral arterial disease - physical examination - claudication

REFERENCES

• 1 Norgren L, Hiatt W R, Dormandy J A, Nehler M R, Harris K A, Fowlkes F GR. Inter-Society for the Management of Peripheral Arterial Disease (TASC II).  J Vasc Surg. 2007;  45(Suppl S) S5-S67
• 2 Hirsch A T, Haskal Z J, Hertzer N R American Association for Vascular Surgery et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.  J Am Coll Cardiol. 2006;  47 1239-1312
• 3 Heart Protection Study Collaborative Group . Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions.  J Vasc Surg. 2007;  45 645-654 discussion 653-654
• 4 Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. The Heart Outcomes Prevention Evaluation Study Investigators . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.  N Engl J Med. 2000;  342 145-153
• 5 Hirsch A T, Criqui M H, Treat-Jacobson D et al.. Peripheral arterial disease detection, awareness, and treatment in primary care.  JAMA. 2001;  286 1317-1324
• 6 Gardner A W, Poehlman E T. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.  JAMA. 1995;  274 975-980
• 7 Thompson P D, Zimet R, Forbes W P, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication.  Am J Cardiol. 2002;  90 1314-1319
• 8 Radack K, Wyderski R J. Conservative management of intermittent claudication.  Ann Intern Med. 1990;  113 135-146